Related references
Note: Only part of the references are listed.A Bayesian paradigm for decision-making in proof-of-concept trials
Erik Pulkstenis et al.
JOURNAL OF BIOPHARMACEUTICAL STATISTICS (2017)
Advantages of a wholly Bayesian approach to assessing efficacy in early drug development: a case study
Rosalind J. Walley et al.
PHARMACEUTICAL STATISTICS (2015)
Elicitation of Expert Prior Opinion: Application to the MYPAN Trial in Childhood Polyarteritis Nodosa
Lisa V. Hampson et al.
PLOS ONE (2015)
Practical considerations for using functional uniform prior distributions for dose-response estimation in clinical trials
Bjoern Bornkamp
BIOMETRICAL JOURNAL (2014)
A web-based tool for eliciting probability distributions from experts
David E. Morris et al.
ENVIRONMENTAL MODELLING & SOFTWARE (2014)
Assurance calculations for planning clinical trials with time-to-event outcomes
Shijie Ren et al.
STATISTICS IN MEDICINE (2014)
Structured approach to the elicitation of expert beliefs for a Bayesian-designed clinicaltrial: a case study
Nelson Kinnersley et al.
PHARMACEUTICAL STATISTICS (2013)
Fitting Emax models to clinical trial dose-response data
Simon Kirby et al.
PHARMACEUTICAL STATISTICS (2011)
Assurance in clinical trial design
A O'Hagan et al.
PHARMACEUTICAL STATISTICS (2005)
Share Paper
